To investigate the efficacy and safety of early transition from hospital to ambulatory treatment in low-risk acute PE, using the oral factor Xa inhibitor rivaroxaban.

Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial

Ageno, Walter
Membro del Collaboration Group
;
2020-01-01

Abstract

To investigate the efficacy and safety of early transition from hospital to ambulatory treatment in low-risk acute PE, using the oral factor Xa inhibitor rivaroxaban.
2020
Home treatment; Management trial; Pulmonary embolism; Right ventricular dysfunction; Risk stratification; Rivaroxaban
Barco, Stefano; Schmidtmann, Irene; Ageno, Walter; Bauersachs, Rupert M; Becattini, Cecilia; Bernardi, Enrico; Beyer-Westendorf, Jan; Bonacchini, Luca; Brachmann, Johannes; Christ, Michael; Czihal, Michael; Duerschmied, Daniel; Empen, Klaus; Espinola-Klein, Christine; Ficker, Joachim H; Fonseca, Cândida; Genth-Zotz, Sabine; Jiménez, David; Harjola, Veli-Pekka; Held, Matthias; Iogna Prat, Lorenzo; Lange, Tobias J; Manolis, Athanasios; Meyer, Andreas; Mustonen, Pirjo; Rauch-Kroehnert, Ursula; Ruiz-Artacho, Pedro; Schellong, Sebastian; Schwaiblmair, Martin; Stahrenberg, Raoul; Westerweel, Peter E; Wild, Philipp S; Konstantinides, Stavros V; Lankeit, Mareike
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11383/2097754
 Attenzione

L'Ateneo sottopone a validazione solo i file PDF allegati

Citazioni
  • ???jsp.display-item.citation.pmc??? 32
  • Scopus 111
  • ???jsp.display-item.citation.isi??? 86
social impact